Compare WAFD & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WAFD | TWST |
|---|---|---|
| Founded | 1917 | 2013 |
| Country | United States | United States |
| Employees | 2037 | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 3.0B |
| IPO Year | N/A | 2018 |
| Metric | WAFD | TWST |
|---|---|---|
| Price | $35.18 | $60.77 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 8 |
| Target Price | $35.00 | ★ $46.88 |
| AVG Volume (30 Days) | 656.6K | ★ 1.2M |
| Earning Date | 04-16-2026 | 05-04-2026 |
| Dividend Yield | ★ 3.05% | N/A |
| EPS Growth | N/A | ★ 63.89 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $376,572,000.00 |
| Revenue This Year | N/A | $18.91 |
| Revenue Next Year | $4.15 | $15.07 |
| P/E Ratio | $11.49 | ★ N/A |
| Revenue Growth | N/A | ★ 20.32 |
| 52 Week Low | $26.31 | $23.30 |
| 52 Week High | $36.02 | $66.06 |
| Indicator | WAFD | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 71.43 | 63.34 |
| Support Level | $31.67 | $41.85 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.73 | 3.52 |
| MACD | 0.29 | 0.76 |
| Stochastic Oscillator | 80.56 | 72.08 |
WaFd Inc is engaged in providing lending, depository, insurance, and other banking services to consumers, mid-sized to large businesses, and owners and developers of commercial real estate. Through the WaFd Bank, it is involved in accepting deposits from the general public and investing these funds in loans of various types, including first-lien mortgages on single-family dwellings, construction loans, land acquisition and development loans among others. The Bank also invests in certain United States government and agency obligations along with other investments and also performs insurance brokerage activities. Geographically, it operates in Washington, Oregon, Idaho, Arizona, Utah, Nevada, New Mexico, California and Texas.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.